RecruitingNCT06400810
Proximal Risk for Suicide in Adolescents
In PortlandSuicidalityObservational studyAges 13–17
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingACTRN12617000400369
PRT MEDIC: Progressive Resistance Training for MEtabolic Syndrome and Depression Integrated Care
Official study title
In AustraliaEffect of Progressive Resistance Training on insulin resistance and depression in adults with Metabolic Syndrome and Major Depressive Disorder.
DepressionInterventional studyAges 40+
RecruitingNCT07242586
PS-Trauma - Development of Trauma Treatment for people with Co-morbid Psychotic Disorders and Traumas
Official study title
In CopenhagenPS-Trauma: Udvikling af Traumebehandling Til Psykiatriske Patienter Med Psykoselidelse - et Pilotstudie.
SchizophreniaBehavioural studyAges 18–35
RecruitingNCT06898606
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression
In Foz do IguaçuDepressionMedication studyAges 25–65
RecruitingEUCTR 2020-005037-32
Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer, a randomized double-blind study with the possibility of entering open extension.
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including Brno-StredDepressionHistorical research record
RecruitingNCT06989957
Psilocybin and Methylenedioxymethamphetamine (MDMA) for PTSD (PTSD)
Official study title
In BaltimorePsilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)
PTSDMedication studyAges 21+
RecruitingNCT07607938
Psilocybin as a Novel Therapy for Residual Anhedonia
Official study title
In New YorkTargeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia
DepressionMedication studyAges 18–65
RecruitingNCT06796062
Psilocybin for Addiction (OUD)
Official study title
Multiple locations, including AlbuquerqueA Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment
AddictionMedication studyAges 18–65
RecruitingNCT04123314
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Official study title
In BaltimorePilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease
DepressionMedication studyAges 18–85
RecruitingNCT06378229
Psilocybin for Hospitalized people with Treatment-resistant Depression
Official study title
In GhentPsilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus
DepressionMedication studyAges 18+
RecruitingNCT06899594
Psilocybin for Methamphetamine Addiction
Official study title
In ShreveportA Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine
AddictionMedication studyAges 25–65
RecruitingNCT06724289
Psilocybin for Prolonged Grief Disorder
Official study title
In CharlottesvillePsilocybin-Assisted Therapy for Prolonged Grief
Prolonged grief disorderMedication studyAges 18–65
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.